1Anderson H,Hopwood P,Stephens RJ,et al.Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer—a randomized trial with quality of life as the primary outcome.UK NSCLC Gemcitabine Group.Non-Small Cell Lung Cancer.Br J Cancer,2000,83:447-453.
2Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer.The Elderly Lung Cancer Vinorelbine Italian Study Group.J Natl Cancer Inst,1999,91:66-72.
3Shepherd FA,Dancey J,Ramlau R,et al.Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.J Clin Oncol,2000,18:2095-2103.
4Ranson M,Davidson N,Nicolson M,et al.Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer.J Natl Cancer Inst,2000,92:1074-1080.
5Schiller JH,Harrington D,Belani CP,et al.Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.N Engl J Med,2002,346:92-98.
6Fossella F,Pereira JR,von Pawel J,et al.Randomized,multinational,phase Ⅲ study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer:the TAX 326 study group.J Clin Oncol,2003,21:3016-3024.
7Smith IE,O'Brien ME,Talbot DC,et al.Duration of chemotherapy in advanced non-small-cell lung cancer:a randomized trial of three versus six courses of mitomycin,vinblastine,and cisplatin.J Clin Oncol,2001,19:1336-1343.
8Georgoulias V,Papadakis E,Alexopoulos A,et al.Platinumbased and non-platinum-based chemotherapy in advanced non-small-cell lung cancer:a randomised multicentre trial.Lancet,2001,357:1478-1484.
9Lilenbaum RC,Herndon JE 2nd,List MA,et al.Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer:the cancer and leukemia group B (study 9730).J Clin Oncol,2005,23:190-196.
10Lilenbaum RC,Langenberg P,Dickersin K.Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma:a meta-analysis of response,toxicity,and survival.Cancer,1998,82:116-126.
